Cell-based therapies for Parkinson disease—past insights and future potential

2015/08/04 by Roger A. Barker, Janelle Drouin-Ouellet, Janelle Drouin‐Ouellet +1 · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Nerve injury and regeneration #Neurological disorders and treatments #Pluripotent Stem Cells Research

paper · doi:10.1038/nrneurol.2015.123

crossref issued 2015/08/04 · crossref published 2015/08/04 · crossref published-online 2015/08/04 · openalex publication_date 2015/08/04 · crossref created 2015/08/04 · crossref published-print 2015/09/01 · crossref deposited 2023/08/12 · openalex created_date 2025/10/10 · crossref indexed 2026/07/18 · openalex updated_date 2026/07/29

Citations

• α-Synuclein in Lewy bodies
• Staging of brain pathology related to sporadic Parkinson’s disease
• Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease
• Human Fetal Dopamine Neurons Grafted Into the Striatum in Two Patients With Severe Parkinson's Disease

Cited by

• Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease

Discussions

• 2/📖 Barker et al. (2015, Nat Rev Neuro) A comprehensive and highly cited review tracing stem cell therapy evolution for PD—from fetal grafts to iPSCs. 📌 A must-read for understanding the field’s roa [bsky, 0 points, 1 comments]